• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过定量构效关系多靶点和分子拓扑学预测苄基苯基醚二胺衍生物的抗原生动物活性。

Predicting antiprotozoal activity of benzyl phenyl ether diamine derivatives through QSAR multi-target and molecular topology.

作者信息

Garcia-Domenech Ramon, Zanni Riccardo, Galvez-Llompart Maria, Galvez Jorge

机构信息

Department of Physical chemistry, University of Valencia, Avenida V.A. Estelles s/n, 46100, Burjassot, Valencia, Spain,

出版信息

Mol Divers. 2015 May;19(2):357-66. doi: 10.1007/s11030-015-9575-5. Epub 2015 Mar 10.

DOI:10.1007/s11030-015-9575-5
PMID:25754076
Abstract

Multi-target QSAR is a novel approach that can predict simultaneously the activity of a given chemical compound on different pharmacological targets. In this work, we have used molecular topology and statistical tools such as multilinear regression analysis and artificial neural networks, to achieve a multi-target QSAR model capable to predict the antiprotozoal activity of a group of benzyl phenyl ether diamine derivatives. The activity was related to three parasites with a high prevalence rate in humans: Trypanosoma brucei rhodesiense, Plasmodium falciparum, and Leishmania donovani. The multi-target model showed a high regression coefficient (R(2) = 0.9644 and R(2) = 0.9235 for training and test sets, respectively) and a low standard error of estimate (SEE = 0.279). Model validation was performed with an external test (R(2) = 0.9001) and a randomization analysis. Finally, the model was applied to the search of potential new active compounds.

摘要

多靶点定量构效关系(QSAR)是一种新型方法,能够同时预测给定化合物对不同药理靶点的活性。在本研究中,我们运用了分子拓扑学和统计工具,如多元线性回归分析和人工神经网络,以建立一个能够预测一组苄基苯基醚二胺衍生物抗寄生虫活性的多靶点QSAR模型。该活性与人类中流行率较高的三种寄生虫有关:布氏罗得西亚锥虫、恶性疟原虫和杜氏利什曼原虫。多靶点模型显示出较高的回归系数(训练集和测试集的R²分别为0.9644和0.9235)以及较低的估计标准误差(SEE = 0.279)。通过外部测试(R² = 0.9001)和随机化分析进行模型验证。最后,该模型被应用于寻找潜在的新型活性化合物。

相似文献

1
Predicting antiprotozoal activity of benzyl phenyl ether diamine derivatives through QSAR multi-target and molecular topology.通过定量构效关系多靶点和分子拓扑学预测苄基苯基醚二胺衍生物的抗原生动物活性。
Mol Divers. 2015 May;19(2):357-66. doi: 10.1007/s11030-015-9575-5. Epub 2015 Mar 10.
2
Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.抗菌剂的统一定量构效关系方法。第3部分:用于抗原生动物化合物的输入编码预测、结构反向投影和复杂网络聚类的首个多任务定量构效关系模型。
Bioorg Med Chem. 2008 Jun 1;16(11):5871-80. doi: 10.1016/j.bmc.2008.04.068. Epub 2008 Apr 29.
3
Role of moving average analysis for development of multi-target (Q)SAR models.移动平均分析在多靶点(定量)构效关系模型开发中的作用。
Mini Rev Med Chem. 2015;15(8):659-76. doi: 10.2174/1389557515666150219130554.
4
Synthesis and antiprotozoal activities of benzyl phenyl ether diamidine derivatives.苯甲基苯醚二脒衍生物的合成及抗原虫活性。
Eur J Med Chem. 2013 Sep;67:310-24. doi: 10.1016/j.ejmech.2013.06.033. Epub 2013 Jun 25.
5
2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins.2D MI-DRAGON:一种新的蛋白配体相互作用预测因子,以及美国 FDA 药物靶点网络、MAO-A 抑制剂和人体寄生虫蛋白的理论-实验研究。
Eur J Med Chem. 2011 Dec;46(12):5838-51. doi: 10.1016/j.ejmech.2011.09.045. Epub 2011 Oct 1.
6
Antiprotozoal activity of Khaya anthotheca, (Welv.) C.D.C. a plant used by chimpanzees for self-medication.药用植物黑檀治疗原虫感染的活性研究,这种植物被黑猩猩用于自我医疗。
J Ethnopharmacol. 2013 May 2;147(1):220-3. doi: 10.1016/j.jep.2013.03.007. Epub 2013 Mar 14.
7
Structure-activity relationship investigations of leishmanicidal N-benzylcytisine derivatives.利什曼原虫杀剂 N-苄基胞啶衍生物的构效关系研究。
Chem Biol Drug Des. 2011 Jul;78(1):183-9. doi: 10.1111/j.1747-0285.2011.01092.x. Epub 2011 May 25.
8
SAR refinement of antileishmanial N(2),N(4)-disubstituted quinazoline-2,4-diamines.抗利什曼原虫的N(2),N(4)-二取代喹唑啉-2,4-二胺的SAR优化
Bioorg Med Chem. 2015 Aug 15;23(16):5182-9. doi: 10.1016/j.bmc.2015.02.020. Epub 2015 Feb 18.
9
Synthesis and in vitro antiprotozoal activities of 5-phenyliminobenzo[a]phenoxazine derivatives.5-苯亚氨基苯并[a]吩嗪衍生物的合成及体外抗原生动物活性。
Bioorg Med Chem Lett. 2011 Oct 1;21(19):5804-7. doi: 10.1016/j.bmcl.2011.07.112. Epub 2011 Aug 5.
10
QSAR analysis for 6-arylpyrazine-2-carboxamides as Trypanosoma brucei inhibitors.作为布氏锥虫抑制剂的6-芳基吡嗪-2-甲酰胺的定量构效关系分析
SAR QSAR Environ Res. 2017 Feb;28(2):165-177. doi: 10.1080/1062936X.2017.1292407.

引用本文的文献

1
QSPR/QSAR: State-of-Art, Weirdness, the Future.QSPR/QSAR:现状、奇异、未来。
Molecules. 2020 Mar 12;25(6):1292. doi: 10.3390/molecules25061292.
2
Molecular topology and QSAR multi-target analysis to boost the in silico research for fungicides in agricultural chemistry.分子拓扑学和定量构效关系多目标分析促进农业化学中杀菌剂的计算研究。
Mol Divers. 2019 May;23(2):371-379. doi: 10.1007/s11030-018-9879-3. Epub 2018 Oct 4.
3
Molecular topology: a strategy to identify novel compounds against ulcerative colitis.分子拓扑学:一种识别抗溃疡性结肠炎新型化合物的策略。

本文引用的文献

1
Understanding drug resistance in malaria parasites: basic science for public health.了解疟原虫的耐药性:公共卫生的基础科学。
Mol Biochem Parasitol. 2014 Jul;195(2):107-14. doi: 10.1016/j.molbiopara.2014.06.001. Epub 2014 Jun 10.
2
Neglected zoonotic diseases-the long and winding road to advocacy.被忽视的动物源性传染病——倡导之路漫漫其修远。
PLoS Negl Trop Dis. 2014 Jun 5;8(6):e2800. doi: 10.1371/journal.pntd.0002800. eCollection 2014 Jun.
3
Antifolate Agents Against Wild and Mutant Strains of Plasmodium falciparum.针对恶性疟原虫野生株和突变株的抗叶酸剂
Mol Divers. 2017 Feb;21(1):219-234. doi: 10.1007/s11030-016-9706-7. Epub 2016 Oct 12.
4
Analysis of B-Raf[Formula: see text] inhibitors using 2D and 3D-QSAR, molecular docking and pharmacophore studies.使用二维和三维定量构效关系、分子对接和药效团研究对B-Raf[公式:见正文]抑制剂进行分析。
Mol Divers. 2015 Nov;19(4):915-30. doi: 10.1007/s11030-015-9626-y. Epub 2015 Aug 15.
Indian J Pharm Sci. 2014 Mar;76(2):116-24.
4
Epidemiology of visceral leishmaniasis.内脏利什曼病的流行病学
Clin Epidemiol. 2014 May 3;6:147-54. doi: 10.2147/CLEP.S44267. eCollection 2014.
5
Design and synthesis of new potent inhibitors of farnesyl pyrophosphate synthase.法尼基焦磷酸合酶新型高效抑制剂的设计与合成
Curr Drug Discov Technol. 2014 Jun;11(2):133-44. doi: 10.2174/15701638113106660041.
6
The double-edged sword in pathogenic trypanosomatids: the pivotal role of mitochondria in oxidative stress and bioenergetics.致病原生动物中的双刃剑:线粒体在氧化应激和生物能量学中的关键作用。
Biomed Res Int. 2014;2014:614014. doi: 10.1155/2014/614014. Epub 2014 Mar 31.
7
Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects.硝基药物治疗原生动物病:过去、现在和未来的前景。
Trends Parasitol. 2014 Jun;30(6):289-98. doi: 10.1016/j.pt.2014.04.003. Epub 2014 Apr 26.
8
Protease inhibitors in potential drug development for Leishmaniasis.用于利什曼病潜在药物开发的蛋白酶抑制剂
Indian J Biochem Biophys. 2013 Oct;50(5):363-76.
9
Human African trypanosomiasis research gets a boost: unraveling the tsetse genome.人类非洲锥虫病研究取得进展:解析采采蝇基因组。
PLoS Negl Trop Dis. 2014 Apr 24;8(4):e2624. doi: 10.1371/journal.pntd.0002624. eCollection 2014 Apr.
10
QSAR multi-target in drug discovery: a review.药物发现中的定量构效关系多靶点研究:综述
Curr Comput Aided Drug Des. 2014;10(2):129-36. doi: 10.2174/157340991002140708105124.